Stocktoria
Dianthus Therapeutics, Inc. /DE/ DNTH
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-06-21
Dianthus Therapeutics, Inc. /DE/ institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 1,025,911 | $100.0M | 2.37% |
| BlackRock Finance, Inc. | 1,603,547 | $41.5M | 3.71% |
| TWO SIGMA INVESTMENTS, LP | 107,455 | $10.5M | 0.25% |
| MILLENNIUM MANAGEMENT LLC | 91,838 | $9.0M | 0.21% |
| D. E. Shaw & Co., Inc. | 42,928 | $4.2M | 0.1% |
| AQR CAPITAL MANAGEMENT LLC | 2,974 | $289,906 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.